Lv1
80 积分 2025-07-28 加入
Low-Dose Corticosteroid Combined With Mycophenolate Mofetil for IgA Nephropathy With Stage 3 or 4 CKD: A Retrospective Cohort Study
1个月前
已完结
Glomerular galactose-deficient IgA1 and apoptosis inhibitor of macrophage staining in secondary IgA nephropathy associated with alcoholic cirrhosis
2个月前
已完结
The beneficial effect of adding belimumab in severe and refractory IgA nephropathy: a case report
4个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
4个月前
已完结
CKD progression, kidney failure, and mortality among US patients with IgA nephropathy
6个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
6个月前
已完结
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression
6个月前
已完结
Favorable changes in the eGFR slope after dapagliflozin treatment and its association with the initial dip
6个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
7个月前
已完结
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
7个月前
已完结
皖公网安备34019202002308
